A single exercise bout augments adenovirus-specific T-cell mobilization and function

被引:16
|
作者
Kunz, Hawley E. [1 ,3 ]
Spielmann, Guillaume [1 ,4 ]
Agha, Nadia H. [1 ]
O'Connor, Daniel P. [1 ]
Bollard, Catherine M. [2 ]
Simpson, Richard J. [1 ,5 ,6 ]
机构
[1] Univ Houston, Dept Hlth & Human Performance, Houston, TX USA
[2] George Washington Univ, Ctr Canc & Immunol Res, Childrens Res Inst, Childrens Natl Hlth Syst, Washington, DC USA
[3] Mayo Clin, Div Endocrinol Diabet Metab & Nutr, Rochester, MN USA
[4] Louisiana State Univ, Sch Kinesiol, Baton Rouge, LA 70803 USA
[5] Univ Arizona, Dept Nutr Sci, Tucson, AZ 85721 USA
[6] Univ Arizona, Dept Immunobiol, Dept Pediat, Tucson, AZ 85721 USA
关键词
Allogeneic hematopoietic stem cell transplantation; Adoptive transfer immunotherapy; ex vivo expansion; Viral infections; Exercise immunology; Acute stress response; PERIPHERAL-BLOOD COMPARTMENT; INFLAMMATORY CYTOKINE; STRENUOUS EXERCISE; VIRAL-INFECTIONS; LYMPHOCYTES; SUBSETS; TRANSPLANTATION; GENERATION; EXPRESSION; MEMORY;
D O I
10.1016/j.physbeh.2018.04.035
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Adoptive transfer of virus-specific T-cells (VSTs) effectively treats viral infections following allogeneic hematopoietic stem cell transplantation (alloHSCT), but logistical difficulties have limited widespread availability of VSTs as a post-transplant therapeutic. A single exercise bout mobilizes VSTs specific for latent herpesviruses (i.e. CMV and EBV) to peripheral blood and augments their ex vivo expansion. We investigated whether exercise exerts similar effects on T-cells specific for a NON-latent virus such as adenovirus, which is a major contributor to infection-related morbidity and mortality after alloHSCT. Thirty minutes of cycling exercise increased circulating adenovirus-specific T-cells 2.0-fold and augmented their ex vivo expansion by similar to 33% compared to rest without altering antigen and MHC-specific autologous target cell killing capabilities. We conclude that exercise is a simple and economical adjuvant to boost the isolation and manufacture of therapeutic VSTs specific to latent and non-latent viruses from healthy donors.
引用
收藏
页码:56 / 65
页数:10
相关论文
共 50 条
  • [21] Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic Leukemia
    Braun, Till
    Stachelscheid, Johanna
    Bley, Nadine
    Oberbeck, Sebastian
    Otte, Moritz
    Muller, Tony Andreas
    Wahnschaffe, Linus
    Glass, Markus
    Ommer, Katharina
    Franitza, Marek
    Gathof, Birgit
    Altmueller, Janine
    Hallek, Michael
    Auguin, Daniel
    Huettelmaier, Stefan
    Schrader, Alexandra
    Herling, Marco
    CANCER RESEARCH, 2022, 82 (09) : 1818 - 1831
  • [22] Adenovirus-specific T-lymphocyte efficacy in the presence of methylprednisolone: An in vitro study
    Campidelli, Arnaud
    Qian, Chongsheng
    Laroye, Caroline
    Decot, Veronique
    Reppel, Loic
    D'Aveni, Maud
    Bensoussan, Daniele
    CYTOTHERAPY, 2018, 20 (04) : 524 - 531
  • [23] T-cell lymphoma gene fusion augments T-cell therapy
    Green, Kathleen J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (07) : 1420 - 1420
  • [24] Transfer of Hexon- and Penton-selected adenovirus-specific T cells for refractory adenovirus infection after haploidentical stem cell transplantation
    Schultze-Florey, Rebecca E.
    Tischer-Zimmermann, Sabine
    Heuft, Hans-Gert
    Priesner, Christoph
    Lamottke, Britta
    Heim, Albert
    Sauer, Martin
    Sykora, Karl-Walter
    Blasczyk, Rainer
    Eiz-Vesper, Britta
    Maecker-Kolhoff, Britta
    TRANSPLANT INFECTIOUS DISEASE, 2020, 22 (01)
  • [25] An oncolytic adenovirus redirected with a tumor-specific T-Cell receptor
    Sebestyen, Zsolt
    de Vrij, Jeroen
    Magnusson, Maria
    Debets, Reno
    Willemsen, Ralph
    CANCER RESEARCH, 2007, 67 (23) : 11309 - 11316
  • [26] VIRAL HEMAGGLUTININ AUGMENTS PEPTIDE-SPECIFIC CYTOTOXIC T-CELL RESPONSES
    ERTEL, C
    MILLAR, NS
    EMMERSON, PT
    SCHIRRMACHER, V
    VONHOEGEN, P
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (10) : 2592 - 2596
  • [27] Clearance of adenovirus load in a recipient of mismatched stem cell transplantation after adoptive transfer of adenovirus-specific T-cells from a haploidentical donor
    Budig, L.
    Lucchini, G.
    Jarisch, A.
    Soerensen, J.
    Koehl, U.
    Boenig, H.
    Klingebiel, T.
    Bader, P.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S147 - S147
  • [28] Clearance of Treatment Refractory Adenoviremia via Adenovirus-specific Donor T-Cell Transfer During Aplasia After αβTCR-CD19-Depleted Stem Cell Transplantation
    Goessling, Katharina L.
    Fouz, Hiba
    Kyrillopoulou, Olga
    Aubin, Matthias
    Maecker-Kolhoff, Britta
    Adams, Ortwin
    Borkhardt, Arndt
    Babor, Florian
    Schuster, Friedhelm R.
    Siepermann, Meinolf
    Schumm, Michael
    Lang, Peter
    Eiz-Vesper, Britta
    Meisel, Roland
    CLINICAL INFECTIOUS DISEASES, 2019, 68 (08) : 1406 - 1409
  • [29] Targeting adenovirus by adoptive immunotherapy: adenovirus capsid hexon is the main target protein of adenovirus-specific CD4+T-cells
    Arbach, O
    Frentsch, M
    Chmielewicz, B
    Kaiser, M
    Voigt, S
    Ellerbrok, H
    Lauster, R
    Radbruch, A
    Scheffold, A
    Ebell, W
    Thiel, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S190 - S190
  • [30] Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine
    Frahm, Nicole
    DeCamp, Allan C.
    Friedrich, David P.
    Carter, Donald K.
    Defawe, Olivier D.
    Kublin, James G.
    Casimiro, Danilo R.
    Duerr, Ann
    Robertson, Michael N.
    Buchbinder, Susan P.
    Huang, Yunda
    Spies, Gregory A.
    De Rosa, Stephen C.
    McElrath, M. Juliana
    JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (01): : 359 - 367